Skip to main content

Table 3 Performance of FPG, 2hPG and HbA1c alone and combining use of FPG (mmol/l) and HbA1c (mmol/mol) in diagnosing diabetes

From: Combining glycosylated hemoglobin A1c and fasting plasma glucose for diagnosis of type 2 diabetes in Chinese adults

Population

Subjects

Diabetes

Se (%)

Sp (%)

PPV

NPV

Individual test

      

 By FPG alonea

6,661

239

52.6

100.0

100.0

96.7

 By 2hPG aloneb

6,422

215

100.0

100.0

100.0

100.0

 By HbA1c alonec

6,661

343

75.6

89.3

34.1

98.0

Combining use of FPG and HbA1c

 All subjects

6,661

380

83.7

89.3

36.4

98.0

Subjects with elevated WCd

2,810

239

83.0

85.8

39.8

97.8

Subjects with elevated TGe

2,385

269

87.4

85.1

42.7

98.2

Subjects with HWf

1,320

162

86.6

82.9

45.5

97.4

  1. aFPG ≥ 7.0 mmol/l; b2 hPG ≥ 11.1 mmol/l; cHbA1c ≥ 43 mmol/mol (6.1%); dWC ≥ 90 cm in men, ≥ 80 cm in women; eTG ≥ 1.695 mmol/l; fhypertriglyceridemic waist phenotype, defined as having both a high WC (≥ 90 cm for men, ≥ 80 cm for women) and an elevated TG level (≥ 1.695 mmol/l).